Literature DB >> 27209345

The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study.

Dirk Fischer1, Patricia Hafner2, Daniela Rubino3, Maurice Schmid3, Cornelia Neuhaus4, Hans Jung5, Oliver Bieri6, Tanja Haas6, Monika Gloor6, Arne Fischmann7, Ulrike Bonati8.   

Abstract

Becker muscular dystrophy (BMD) has an incidence of 1 in 16 000 male births. This cross-sectional study investigated the relation between validated functional scores and quantitative MRI (qMRI) of thigh muscles in 20 ambulatory BMD patients, aged 18.3-60 years (mean 31.2; SD 11.1). Clinical assessments included the motor function measure (MFM) and its subscales, as well as timed function tests such as the 6-minute walk test (6MWT) and the timed 10-m run/walk test. Quantitative MRI of the thigh muscles included the mean fat fraction (MFF) using a 2-point Dixon (2-PD) technique, and transverse relaxation time (T2) measurements. The mean MFM value was 80.4%, SD 9.44 and the D1 subscore 54.5%, SD 19.9. The median 6MWT was 195m, IQR 160-330.2. The median 10-m run/walk test was 7.4 seconds, IQR 6.1-9.3. The mean fat fraction of the thigh muscles was 55.6%, SD 17.4%, mean T2 relaxation times of all muscles: 69.9 ms, SD 14.4. The flexors had the highest MFF and T2 relaxation times, followed by the extensors and the adductors. MFF and global T2 relaxation times were highly negatively correlated with the MFM total, D1-subscore and 6MWT, and positively correlated with the 10 m run/walk test time (p < 0.01). Age was not correlated with MFF, global T2 relaxation time or clinical assessments. Both MFF and T2 measures in the thigh muscle were well correlated with clinical function in BMD and may serve as a surrogate outcome measure in clinical trials.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Becker muscular dystrophy; Dystrophinopathy; Imaging biomarker; Quantitative MR; Timed function tests

Mesh:

Year:  2016        PMID: 27209345     DOI: 10.1016/j.nmd.2016.04.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  18 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

Review 2.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

3.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

4.  MRI correlates of motoneuron loss in SMA.

Authors:  Alina Sprenger-Svačina; Johannes Haensch; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Natalie Schloss; Kai Laukamp; Gilbert Wunderlich; Helmar C Lehmann; Thorsten Lichtenstein
Journal:  J Neurol       Date:  2022-10-01       Impact factor: 6.682

5.  Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.

Authors:  Harmen Reyngoudt; Benjamin Marty; Jean-Marc Boisserie; Julien Le Louër; Cedi Koumako; Pierre-Yves Baudin; Brenda Wong; Tanya Stojkovic; Anthony Béhin; Teresa Gidaro; Yves Allenbach; Olivier Benveniste; Laurent Servais; Pierre G Carlier
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

Review 6.  [Imaging of primary muscular diseases : What do neurologists expect from radiologists?]

Authors:  M P Wattjes; A Fischmann; D Fischer
Journal:  Radiologe       Date:  2017-12       Impact factor: 0.635

7.  Function, structure and quality of striated muscles in the lower extremities in patients with late onset Pompe Disease-an MRI study.

Authors:  Michael Vaeggemose; Rosa Andersen Mencagli; Julie Schjødtz Hansen; Bianca Dräger; Steffen Ringgaard; John Vissing; Henning Andersen
Journal:  PeerJ       Date:  2021-05-06       Impact factor: 2.984

8.  Baseline fat fraction is a strong predictor of disease progression in Becker muscular dystrophy.

Authors:  Thom T J Veeger; Nienke M van de Velde; Kevin R Keene; Erik H Niks; Melissa T Hooijmans; Andrew G Webb; Jurriaan H de Groot; Hermien E Kan
Journal:  NMR Biomed       Date:  2022-02-05       Impact factor: 4.478

9.  Patients With Becker Muscular Dystrophy Have Severe Paraspinal Muscle Involvement.

Authors:  Aisha M Sheikh; Karen Rudolf; Josefine de Stricker Borch; Tahmina Khawajazada; Nanna Witting; John Vissing
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

10.  Use of EP3533-Enhanced Magnetic Resonance Imaging as a Measure of Disease Progression in Skeletal Muscle of mdx Mice.

Authors:  Alexander Peter Murphy; Elizabeth Greally; Dara O'Hogain; Andrew Blamire; Peter Caravan; Volker Straub
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.